Definitive Contract 75N95020C00024
Award Date
9/24/20
Potential Completion Date
9/27/24
Potential Value
$1.5M
Federal Agency
National Institute on Drug Abuse
Awardee
Soterix Medical, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Soterix Medical, Inc. for a Small Business Innovation Research (SBIR) Phase I project to develop transcranial direct current stimulation (tDCS) technology to reduce craving in cocaine addiction. The base award has a potential value of $476,863.98 and a period of performance from September 2018 to November 2019. Soterix Medical is a manufacturer of...
This $154,739.20 firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Magventure, Inc., a for-profit medical device manufacturer. The contract is for the delivery of a Transcranial Magnetic Stimulation (TMS) research system to support NIDA's Cellular and Neurocomputational Systems Branch and its Learning and Decision Making Unit. The system will be used for non-invasive brain...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Magventure, Inc., a medical device manufacturer that specializes in transcranial magnetic stimulation (TMS) systems. The $83,660 firm fixed-price contract is for the supply of TMS products and services to support NIDA's biomedical research projects. This contract is not associated with a larger contract vehicle and does not have a set-aside...
This firm fixed-price purchase order contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Soterix Medical, Inc. (doing business as Soterix Medical Technologies), a manufacturer of medical devices and equipment. The $25,000.00 contract is for the delivery of Soterix Medical's non-invasive neuromodulation technologies, which have been used in past federal research and development efforts for treatments related to pain,...
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small...
This is a firm fixed-price purchase order awarded to Magstim Inc., a self-certified small disadvantaged business, by the National Institute on Drug Abuse (NIDA), a civilian agency. The $112,725.00 contract is for the delivery of unspecified medical and research devices in the neurological and surgical fields, with a period of performance running through May 20, 2025. While no set-aside was used, Magstim Inc. has previously been awarded numerous Federal contracts, primarily from the Department of...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B & W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,250.00, is for the delivery of Brainbox LTD's NEUROFUS DEEP TRANSDUCER, a specialized medical device used to modulate neural activity in deeper areas of the human brain. This technology supports NIDA's research efforts, which include the study of addiction and other neurological conditions. The...
The Department of Health and Human Services' National Institute on Drug Abuse awarded a $10,455 firm-fixed-price purchase order contract to Brainbox LTD, a for-profit company specializing in non-invasive brain stimulation and imaging solutions. The purpose of the contract is to provide Brainbox's K-Plan software to be used with a transducer to modulate neural activity in deeper areas of the human brain, in support of research conducted by Drs. Ross and Kahnt. The contract has an ultimate...
This is a $806,041.38 cost-plus-fixed-fee task order awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA) for the "Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder (CTN-0108)" study. The task order, which has a period of performance from 9/21/2020 to 7/17/2023, is part of NIDA's "Data, Statistics, and Clinical Trial Support Center" major program. The Emmes Company, a for-profit limited liability company...